US Stock MarketDetailed Quotes
BSPM Biostar Pharmaceuticals
- 0.000100
- 0.0000000.00%
15min DelayClose Nov 26 16:00 ET
263.72Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000100Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)2.64MShares0.00950052wk High0.00P/B221.02Float Cap0.00000152wk Low--Dividend TTM2.21MShs Float1.880000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
Biostar Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | (Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | (Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -100.25%-1.41K | 39,358.21%4.27M | -6.33%321.13K | -16.41%4.91M | -34.23%4M | 186.24%557.42K | 100.45%10.81K | -87.91%342.82K | 77.53%5.88M | 57.82%6.08M |
| Net income from continuing operations | 91.99%-125.19K | 80.96%-1.31M | -63.48%-1.01M | 77.31%-5.7M | 114.60%3.39M | -24.62%-1.56M | -1,301.72%-6.9M | -287.46%-620.34K | -617.98%-25.11M | -973.53%-23.21M |
| Operating gains losses | -500.88%-12.93K | -1,505.74%-259.44K | 39.82%-16.97K | -154.76%-227.11K | -128.25%-180.61K | 98.51%-2.15K | 82.11%-16.16K | -385.71%-28.19K | 124.86%414.74K | 148.08%639.41K |
| Depreciation and amortization | -25.04%300.24K | 43.77%281.77K | -6.01%297.83K | -50.76%1.14M | -82.57%229.14K | 1,350.04%400.53K | -60.04%195.99K | -34.99%316.88K | -24.82%2.32M | 112.92%1.31M |
| Deferred tax | ---- | ---- | --0 | 99.04%2.65M | ---- | ---- | ---- | 87.84%-58.23K | 131.11%1.33M | 149.97%1.91M |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 45.36%4.02M | 125.15%3.96M |
| Change In working capital | -170.58%-163.54K | 1,508.68%5.56M | 43.91%1.05M | 36.64%7.31M | 11.25%6M | -76.05%231.71K | 110.51%345.49K | -67.81%732.7K | 188.03%5.35M | 56.09%5.39M |
| -Change in receivables | -35.52%69.26K | 1,714.36%5.57M | 4.01%1.24M | 59.13%8.67M | -30.36%7.06M | 105.92%107.43K | 105.74%307.09K | -51.77%1.19M | 173.21%5.45M | 119.42%10.14M |
| -Change in inventory | 100.03%32 | 100.02%7 | 105.61%3.16K | -86.89%55.15K | -32.84%269.17K | 11.86%-124.57K | 72.36%-33.03K | -120.11%-56.42K | 175.88%420.58K | 497.66%400.79K |
| -Change in prepaid assets | ---135.62K | ---172.81K | --155.24K | -144.92%-176.29K | 90.85%-176.29K | --0 | --0 | --0 | 60.65%392.43K | -35.00%-1.93M |
| -Change in payables and accrued expense | -139.07%-97.22K | 122.55%158.97K | 14.73%-342.26K | -35.92%-1.24M | 64.06%-1.16M | -82.53%248.85K | -95.09%71.43K | 28.85%-401.36K | -194.22%-912.85K | -1,789.03%-3.23M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -100.25%-1.41K | 39,358.21%4.27M | -6.33%321.13K | -16.41%4.91M | -34.23%4M | 186.24%557.42K | 100.45%10.81K | -87.91%342.82K | 77.53%5.88M | 57.82%6.08M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -44.38K | 13.55%-6.38M | -11.43%-6.38M | 0 | 16.90%-7.38M | 42.52%-5.72M | ||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 97.93%-59.48K | 98.79%-28.95K |
| Net business purchase and sale | ---44.38K | ---- | ---- | 21.47%-6.38M | 1.86%-6.38M | --0 | ---- | ---- | -66.39%-8.12M | -33.14%-6.5M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 130.04%804.18K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---44.38K | ---4.36M | --0 | 13.55%-6.38M | -11.43%-6.38M | --0 | --0 | --0 | 16.90%-7.38M | 42.52%-5.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 977.41%1.41M | 6,450.29%1.69M | 30.05%1.89K | 99.29%-178 | -73.47%-282.73K | -102.31%-160.84K | 111.09%25.83K |
| Net issuance payments of debt | --0 | --0 | --0 | -73.04%-278.32K | -89.54%2.7K | 30.05%1.89K | 99.29%-178 | -73.47%-282.73K | -105.20%-160.84K | 111.09%25.83K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --1.69M | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | 977.41%1.41M | 6,450.29%1.69M | 30.05%1.89K | 99.29%-178 | -73.47%-282.73K | -102.31%-160.84K | 111.09%25.83K |
| Net cash flow | ||||||||||
| Beginning cash position | 96.71%407.41K | 428.91%483.86K | 345.50%173.29K | -97.69%38.9K | 489.18%659.36K | -33.90%207.11K | -96.62%91.48K | -97.69%38.9K | 2,004.55%1.69M | -98.57%111.91K |
| Current changes in cash | -108.19%-45.79K | -1,020.34%-97.86K | 434.35%321.13K | 96.73%-54.29K | -277.25%-684.33K | 188.49%559.31K | 100.44%10.63K | -94.06%60.1K | -219.80%-1.66M | 106.09%386.08K |
| Effect of exchange rate changes | 103.13%3.36K | -79.61%21.41K | -40.57%-10.56K | 1,166.64%188.68K | 143.18%198.26K | -124.86%-107.06K | 241.94%105K | -159.56%-7.51K | -93.18%14.9K | -307.45%-459.09K |
| End cash Position | -44.65%364.97K | 96.71%407.41K | 428.91%483.86K | 345.50%173.29K | 345.50%173.29K | 489.18%659.36K | -33.90%207.11K | -96.62%91.48K | -97.69%38.9K | -97.69%38.9K |
| Free cash flow | -100.25%-1.41K | 39,358.21%4.27M | -6.33%321.13K | -15.56%4.91M | -33.91%4M | 186.27%557.42K | 100.45%10.81K | -87.78%342.82K | 1,217.98%5.82M | 311.73%6.06M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
